| 1287 |
ISAR-TEST-2 Trial : Two-year Clinical and Angiographic Outcomes from a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents |
|
Oct. 18. 10 |
| 1286 |
Endovascular Valve Edge-to-Edge Repair Study (EVEREST Ⅱ) Randomized Clinical Trial: Primary Safety and Efficacy Endpoints |
|
Oct. 18. 10 |
| 1285 |
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial |
|
Oct. 18. 10 |
| 1284 |
Five year clinical follow-up of the PASSION-trial |
|
Oct. 18. 10 |
| 1283 |
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation : A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial |
|
Oct. 18. 10 |
| 1282 |
Long-Term Safety and Efficacy of Stenting versus Coronary-Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results From the MAINCOMPARE Registry |
|
Oct. 18. 10 |
| 1281 |
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial |
|
Oct. 18. 10 |
| 1280 |
Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease – Findings from the INternational VErapamil SR – Trandolapril STudy (INVEST) |
|
Oct. 18. 10 |
| 1279 |
The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial : The Value of Remote Monitoring |
|
Oct. 18. 10 |
| 1278 |
Long Term Clinical Results from the Endeavor Program: 5-Year Follow up |
|
Oct. 18. 10 |
